EX-1.1 2 dp79365_ex0101.htm EXHIBIT 1.1

Exhibit 1.1

 

PRICING AGREEMENT

 

J.P. Morgan Securities LLC 

Merrill Lynch, Pierce, Fenner & Smith 

Incorporated 

Mizuho Securities USA LLC 

Morgan Stanley & Co. LLC 

As Representatives of the several
Underwriters named in Schedule I hereto 

August 7, 2017

 

Ladies and Gentlemen:

 

Aetna Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and conditions stated herein and in the Underwriting Agreement, dated May 1, 2012 (the “Underwriting Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) the debt securities specified in Schedule II hereto (the “Designated Securities”). Each of the provisions of the Underwriting Agreement is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein; and each of the representations and warranties set forth therein shall be deemed to have been made at and as of the date of this Pricing Agreement. Each reference to the Representatives herein and in the provisions of the Underwriting Agreement so incorporated by reference shall be deemed to refer to you. Unless otherwise defined herein, terms defined in the Underwriting Agreement are used herein as therein defined. The registration statement on Form S-3 (File No. 333-178272) referred to in Section 2 of the Underwriting Agreement shall be deemed to refer to the registration statement on Form S-3 (File No. 333-200647). The Representatives designated to act on behalf of each of the Underwriters of the Designated Securities pursuant to Section 15 of the Underwriting Agreement and the addresses of the Representatives referred to in such Section 15 are set forth at the end of Schedule II hereto.

 

Subject to the terms and conditions set forth herein and in the Underwriting Agreement incorporated herein by reference, the Company agrees to issue and to sell to each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at the time and place and at the purchase price to the Underwriters set forth in Schedule II hereto, the principal amount of Designated Securities set forth opposite the name of such Underwriter in Schedule I hereto, less the principal amount of Designated Securities covered by Delayed Delivery Contracts, if any, as may be specified in Schedule II hereto.

 

The Company further represents and warrants to, and agrees with, each of the Underwriters, as of the date hereof and as of the Time of Delivery for the Designated Securities, that:

 

a)The Company is not, and after giving effect to the offering and sale of the Designated Securities and the application of the proceeds thereof will not be, an “investment company,” as such term is defined in the Investment Company Act of 1940, as amended;

 

b)None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is aware of, or has taken any action, directly or indirectly, that would result in, a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), in any material respect including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization

 

 

 

of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA; and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA in all material respects and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued material compliance therewith;

 

c)The operations of the Company and its subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened; and

 

d)None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any sanctions administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) and the Company will not directly or indirectly use the proceeds of the sale of the Designated Securities, or lend, contribute or otherwise make available such proceeds, to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any sanctions administered by OFAC.

 

If the foregoing is in accordance with your understanding, please sign and return to us counterparts hereof, and upon acceptance hereof by you, on behalf of each of the Underwriters, this letter and such acceptance hereof, including the provisions of the Underwriting Agreement incorporated herein by reference, shall constitute a binding agreement between each of the Underwriters and the Company.

 

[Signature Pages Follow]

 

2

 

It is understood that your acceptance of this letter on behalf of each of the Underwriters is or will be pursuant to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Company for examination upon request.

 

Very truly yours,
 
AETNA INC.
 
 
 
By /s/ David Buda
  Name: David Buda
  Title: Vice President, Finance and Treasurer

Accepted as of the date hereof:

 

J.P. Morgan Securities LLC 

Merrill Lynch, Pierce, Fenner & Smith 

Incorporated 

Mizuho Securities USA LLC 

Morgan Stanley & Co. LLC

 

On behalf of each of the
Underwriters

 

By: J.P. Morgan Securities LLC

 

By /s/ Som Bhattacharyya
  Name: Som Bhattacharyya
  Title: Executive Director

 

By: Merrill Lynch, Pierce, Fenner & Smith 

Incorporated

 

By /s/ Jacqueline Cleary
  Name: Jacqueline Cleary
  Title: Managing Director

 

By: Mizuho Securities USA LLC

 

By /s/ Thomas Bausano
  Name: Thomas Bausano
  Title: Managing Director

 

By: Morgan Stanley & Co. LLC

 

By /s/ Yiruj Slyz
  Name: Yurij Slyz
  Title: Executive Director

 

3

 

SCHEDULE I

 

TO PRICING AGREEMENT

 

Underwriter Principal Amount of 3.875% Senior Notes due 2047 to be Purchased
J.P. Morgan Securities LLC $180,000,000
Merrill Lynch, Pierce, Fenner & Smith Incorporated $180,000,000
Mizuho Securities USA LLC $180,000,000
Morgan Stanley & Co. LLC $180,000,000
Barclays Capital Inc. $25,600,000
Citigroup Global Markets Inc. $25,600,000
Credit Suisse Securities (USA) LLC $25,600,000
Goldman Sachs & Co. LLC $25,600,000
MUFG Securities Americas Inc. $25,600,000
PNC Capital Markets LLC $25,600,000
SunTrust Robinson Humphrey, Inc. $25,600,000
U.S. Bancorp Investments, Inc. $25,600,000
UBS Securities LLC $25,600,000
Wells Fargo Securities, LLC $25,600,000
BNY Mellon Capital Markets, LLC $8,000,000
Fifth Third Securities, Inc. $8,000,000
HSBC Securities (USA) Inc. $8,000,000
Total $1,000,000,000

 

 I-1

 

SCHEDULE II

 

TO PRICING AGREEMENT

 

TITLE OF DESIGNATED SECURITIES:

 

3.875% Senior Notes due 2047 (the “Notes”)

 

 

AGGREGATE PRINCIPAL AMOUNT:

 

$1,000,000,000

 

 

PRICE TO PUBLIC:

 

99.682% of the aggregate principal amount of the Notes, plus accrued interest, if any, from August 10, 2017 if settlement occurs after that date. 

 

 

PURCHASE PRICE BY UNDERWRITERS:

 

98.932% of the aggregate principal amount of the Notes, plus accrued interest, if any, from August 10, 2017 if settlement occurs after that date.

 

 

SPECIFIED FUNDS FOR PAYMENT OF PURCHASE PRICE:

 

Immediately available funds delivered to the bank account(s) specified in the cross-receipt to the Underwriters.

 

 

INDENTURE:

 

Senior Indenture dated as of March 2, 2001, between the Company and U.S. Bank National Association, successor in interest to State Street Bank and Trust Company, as trustee (the “Trustee”) (the “Base Indenture”), as supplemented by the Supplemental Indenture to be dated on or prior to August 10, 2017, between the Company and the Trustee (as so supplemented, the “Indenture”).

 

II-1

 

MATURITY:

 

August 15, 2047

 

 

INTEREST RATE:

 

3.875% per annum

 

 

INTEREST PAYMENT DATES:

 

Semi-annually on February 15 and August 15 of each year, beginning February 15, 2018.

 

In any case where any interest payment date is not a business day, payment of interest may be made on the next succeeding business day without any additional amount being payable in respect of any delay.

 

 

REDEMPTION PROVISIONS:

 

Optional Redemption

 

At any time prior to February 15, 2047 (six months prior to the maturity date of the Notes), the Notes may be redeemed, in whole or in part, at the option of the Company, at a redemption price equal to the greater of (a) 100% of the principal amount of the Notes being redeemed; or (b) the sum of the present value of (i) 100% of the principal amount of the Notes being redeemed and (ii) all required remaining scheduled interest payments due on the Notes being redeemed, in each case calculated as if the maturity date of the Notes were February 15, 2047 (six months prior to the maturity date of the Notes), discounted to, but excluding, the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined below) plus 20 basis points; plus, in each case, any interest accrued but not paid to, but excluding, the date of redemption.

 

At any time on or after February 15, 2047 (six months prior to the maturity date of the Notes), the Notes may be redeemed, in whole or in part, at the option of the Company, at a redemption price equal to 100% of the principal amount of the Notes being redeemed plus any interest accrued but not paid to, but excluding, the date of redemption.

 

Certain Definitions

 

Treasury Rate” means, with respect to any redemption date for any portion of the Notes,

 

·the yield, under the heading which represents the average for the immediately preceding week, appearing in, or available through, the most recently published statistical release designated “H.15” or any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities adjusted to constant maturity under the caption “Treasury Constant Maturities,” for the maturity corresponding to the Comparable Treasury Issue (if no maturity is within three months before or after the Remaining Life for the Notes, yields for the two

 

II-2

 

published maturities most closely corresponding to the Comparable Treasury Issue will be determined, and the Treasury Rate shall be interpolated or extrapolated from those yields on a straight line basis, rounding to the nearest month), or

 

·if the release referred to in the previous bullet (or any successor release) is not published during the week preceding the calculation date or does not contain the yields referred to above, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that redemption date.

 

The Treasury Rate will be calculated on the third business day preceding the redemption date.

 

Comparable Treasury Issue” means the United States Treasury security selected by an Independent Investment Banker as having an actual or interpolated maturity comparable to the remaining term of the Notes to be redeemed, calculated as if the maturity date of the Notes were February 15, 2047 (the “Remaining Life”) that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the Remaining Life of the Notes to be redeemed.

 

Comparable Treasury Price” means, with respect to any redemption date for any Notes, the average of all Reference Treasury Dealer Quotations (as defined below) obtained.

 

Independent Investment Banker” means one of the Reference Treasury Dealers appointed by the Company.

 

Reference Treasury Dealer” means each of J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Mizuho Securities USA LLC and Morgan Stanley & Co. LLC. If any Reference Treasury Dealer ceases to be a primary U.S. government securities dealer in the United States (a “Primary Treasury Dealer”), the Company will substitute another Primary Treasury Dealer for that dealer.

 

Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Company by that Reference Treasury Dealer at 5:00 p.m. on the third business day preceding the redemption date.

 

Notice; Interest

 

Notice of any redemption will be mailed at least 15 days but no more than 60 days before the redemption date to each holder of Notes to be redeemed.

 

Unless the Company defaults in payment of the redemption price, interest will cease to accrue on the Notes or the portions of the Notes called for redemption on and after the redemption date.

 

II-3

 

REPURCHASE PROVISIONS:

 

Repurchase Upon a Change of Control

 

If a Change of Control Triggering Event occurs, unless the Company has exercised its right to redeem the Notes in full, as described under “Optional Redemption” above, the Company will make an offer to each holder of Notes (the “Change of Control Offer”) to repurchase any and all (equal to $2,000 or an integral multiple of $1,000) of such holder’s Notes at a repurchase price in cash equal to 101% of the aggregate principal amount of the Notes to be repurchased plus accrued and unpaid interest, if any, thereon, to, but excluding, the date of repurchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering Event, the Company will be required to mail a notice to holders of the Notes describing the transaction or transactions that constitute the Change of Control Triggering Event and offering to repurchase the Notes on the date specified in the notice (the “Change of Control Payment Date”), which date will be no less than 30 days and no more than 60 days from the date such notice is mailed, pursuant to the procedures required by the Notes and described in such notice. The Company must comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control repurchase provisions of the Notes, the Company will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under the Change of Control repurchase provisions of the Notes by virtue of such conflicts.

 

The Company will not be required to offer to repurchase the Notes upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company, and the third party repurchases on the applicable date all Notes properly tendered and not withdrawn under its offer; provided that for all purposes of the Notes and the Indenture, a failure by such third party to comply with the requirements of such offer and to complete such offer shall be treated as a failure by the Company to comply with its obligations to offer to purchase the Notes unless the Company promptly makes an offer to repurchase the Notes at 101% of the outstanding principal amount thereof plus accrued and unpaid interest, if any, thereon, to, but excluding, the date of repurchase, which shall be no later than 30 days after the third party’s scheduled Change of Control Payment Date.

 

On the Change of Control Payment Date, the Company will be required, to the extent lawful, to:

 

·accept or cause a third party to accept for payment all Notes or portions of Notes properly tendered pursuant to the Change of Control Offer;

 

·deposit or cause a third party to deposit with the paying agent an amount equal to the Change of Control Payment in respect of each Note or portion of a Note properly tendered; and

 

·deliver or cause to be delivered to the Trustee the Notes properly accepted, together with an officer’s certificate stating the aggregate principal amount of Notes or portions of Notes being purchased.

 

For purposes of the foregoing discussion of the applicable Change of Control provisions, the following definitions are applicable:

 

Below Investment Grade Rating Event” means the Notes are rated below an Investment Grade Rating by each of the Rating Agencies on any date from the earlier of (1) the occurrence of a Change of Control and (2) public notice of the Company’s intention to effect a Change of Control, in each case until

 

II-4

 

the end of the 60-day period following the earlier of (1) the occurrence of a Change of Control and (2) public notice of the Company’s intention to effect a Change of Control; provided, however, that if (i) during such 60-day period one or more Rating Agencies has publicly announced that it is considering the possible downgrade of the Notes, and (ii) a downgrade by each of the Rating Agencies that has made such an announcement would result in a Below Investment Grade Rating Event, then such 60-day period shall be extended for such time as the rating of the Notes by any such Rating Agency remains under publicly announced consideration for possible downgrade to a rating below an Investment Grade Rating and a downgrade by such Rating Agency to a rating below an Investment Grade Rating could cause a Below Investment Grade Rating Event. Notwithstanding the foregoing, a rating event otherwise arising by virtue of a particular reduction in rating will not be deemed to have occurred in respect of a particular Change of Control (and thus will not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Triggering Event) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing at the Company’s or the Trustee’s request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control has occurred at the time of the rating event).

 

Change of Control” means the occurrence of any of the following: (1) direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the properties or assets of the Company and its subsidiaries taken as a whole to any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than to the Company or one of its subsidiaries; or (2) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its subsidiaries becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of the Company’s voting stock; provided, however, that a transaction will not be deemed to involve a Change of Control if (A) the Company becomes a wholly owned subsidiary of a holding company and (B)(x) the holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of the Company’s voting stock immediately prior to that transaction or (y) immediately following that transaction no “person” (as that term is used in Section 13(d)(3) of the Exchange Act) is the beneficial owner, directly or indirectly, of more than 50% of the voting stock of such holding company. For purposes of this definition, “voting stock” means capital stock of any class or kind the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of the Company (even if the right to vote has been suspended by the happening of such a contingency).

 

Change of Control Triggering Event” means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.

 

Fitch” means Fitch Ratings, Inc. and its successors.

 

Investment Grade Rating” means a rating by Moody’s equal to or higher than Baa3 (or the equivalent under any successor rating category of Moody’s), a rating by S&P equal to or higher than BBB- (or the equivalent under any successor rating category of S&P), a rating by Fitch equal to or higher than BBB- (or the equivalent under any successor rating category of Fitch), and the equivalent investment grade credit rating from any replacement rating agency or rating agencies selected by the Company under circumstances permitting the Company to select a replacement rating agency and in the manner for selecting a replacement rating agency, in each case as set forth in the definition of “Rating Agencies.”

 

Moody’s” means Moody’s Investors Service, Inc. and its successors.

 

II-5

 

Rating Agencies” means (1) Moody’s, S&P and Fitch; and (2) if any or all of Moody’s, S&P or Fitch ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) of the Exchange Act that the Company selects as a replacement rating agency for any of Moody’s, S&P or Fitch, or all of them, as the case may be, with respect to the Notes.

 

S&P” means S&P Global Ratings, a division of S&P Global Inc., and its successors.

 

SINKING FUND PROVISIONS: 

No sinking fund provisions.

 

 

TIME OF DELIVERY:

 

9:00 a.m. Eastern Time on August 10, 2017

 

 

CLOSING LOCATION:

 

Davis Polk & Wardwell LLP, 450 Lexington Avenue, New York, New York 10017

 

 

 

NAMES AND ADDRESSES OF REPRESENTATIVES:

 

J.P. Morgan Securities LLC 

383 Madison Avenue 

New York, NY 10179 

Attention: Investment Grade Syndicate Desk – 3rd floor 

Facsimile No.: +1 (212) 834 6081

 

Merrill Lynch, Pierce, Fenner & Smith 

Incorporated 

50 Rockefeller Plaza 

NY1-050-12-01 

New York, NY 10020 

Attention: High Grade Debt Capital Markets Transaction Management/Legal 

Facsimile No.: 212-901-7881

 

Mizuho Securities USA LLC 

320 Park Avenue – 12th Floor 

New York, NY 10022 

Attention: Debt Capital Markets Desk 

Facsimile No.: (212) 205-7812

 

Morgan Stanley & Co. LLC 

1585 Broadway, 29th Floor

 

II-6

 

New York, NY 10036 

Attention: Investment Banking Division 

Facsimile No.: (212) 507-8999

 

OTHER TERMS:

 

The holders of the Notes will not have the benefit of clause (5) of Section 501 of the Base Indenture entitled “Events of Default.”

 

The holders of the Notes will not have the benefit of Section 1005 of the Base Indenture entitled “Limitations on Liens on Common Stock of Principal Subsidiaries.”

 

Delivery of the Notes will be made against payment therefor on the third business day following the date of pricing of the Notes (such settlement cycle being herein referred to as “T+3”)

 

II-7

 

SCHEDULE III

 

TO PRICING AGREEMENT

 

Time of Sale

 

2:54 p.m. Eastern Time on August 7, 2017

 

Time of Sale Information

 

Preliminary Prospectus dated August 7, 2017

 

Free Writing Prospectus dated August 7, 2017

 

III-1

 

SCHEDULE IV

 

TO PRICING AGREEMENT

 

Pricing Term Sheet for Designated Securities

 

of Aetna Inc. (the “Issuer”)

 

This pricing term sheet is qualified in its entirety by reference to the preliminary prospectus supplement dated August 7, 2017 filed by the Issuer with the SEC pursuant to Rule 424(b)(3) (the “Preliminary Prospectus Supplement”). The information in this pricing term sheet supplements the Preliminary Prospectus Supplement and updates and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Terms used and not defined herein have the respective meanings assigned to them in the Preliminary Prospectus Supplement.

 

Issuer: Aetna Inc.
Note Type: Senior Notes
Legal Format: SEC Registered
Trade Date: August 7, 2017
Settlement Date (T+3): August 10, 2017
Principal Amount: $1,000,000,000
Maturity Date:    August 15, 2047
Coupon:    3.875%
Interest Payment Frequency: Semi-Annually
Interest Payment Dates: February 15 and August 15
First Interest Payment Date:    February 15, 2018
Day Count:    30/360
Pricing Benchmark: 3.000% due February 15, 2047
Benchmark Spot: 103-04
Benchmark Yield:        2.843%
Reoffer Spread to Benchmark Treasury:        105 basis points
Reoffer Yield:        3.893%
Price to Public / Reoffer Price:        99.682%

 

IV-1

 

Underwriting Fees: 0.750%
Use of Proceeds: The net proceeds are expected to be used to repay a portion of the Issuer’s 1.5% Senior Notes due 2017 and the Issuer’s floating rate Senior Notes due 2017 and for general corporate purposes.
Optional Redemption:

At any time prior to February 15, 2047, at the greater of 100% of the principal amount of the Notes being redeemed or at a make whole price using a discount rate of Treasury plus 20 basis points.

 

On or after February 15, 2047, redeemable at par.

CUSIP Number: 00817Y AZ1
ISIN Number: US00817YAZ16
Minimum Denomination: $2,000 and multiples of $1,000 in excess thereof
Joint Book-Running Managers:

J.P. Morgan Securities LLC 

Merrill Lynch, Pierce, Fenner & Smith 

Incorporated

Mizuho Securities USA LLC 

Morgan Stanley & Co. LLC 

Senior Co-Managers:   

Barclays Capital Inc. 

Citigroup Global Markets Inc. 

Credit Suisse Securities (USA) LLC 

Goldman Sachs & Co. LLC 

MUFG Securities Americas Inc. 

PNC Capital Markets LLC 

SunTrust Robinson Humphrey, Inc. 

U.S. Bancorp Investments, Inc. 

UBS Securities LLC 

Wells Fargo Securities, LLC 

Co-Managers:

BNY Mellon Capital Markets, LLC 

Fifth Third Securities, Inc. 

HSBC Securities (USA) Inc. 

 

The Issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates.  Before you invest, you should read the prospectus in that registration statement and the other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling J.P. Morgan Securities LLC at 1-212-834-4533 (collect), Merrill Lynch, Pierce, Fenner & Smith Incorporated at 1-800-294-1322 (toll-free), Mizuho Securities USA LLC at 1-866-271-7403

 

IV-2

 

(toll-free) or Morgan Stanley & Co. LLC by phone at 1-866-718-1649 (toll-free) or by e-mail at prospectus@morganstanley.com.

 

IV-3